Guardant Health, Inc. (GH) Market Cap & Valuation Ratios
Guardant Health, Inc. (GH) has a market cap of $22.7B and a price-to-sales ratio of 19.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GHGuardant Health, Inc.Follow GH — free
—
Price chart with a free account
- Market cap
- 22.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 11 days
Peers
diagnostics & research · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| GH | 23 | — | 19.6 | — | -1.1% | +43% | -40% | -231% |
| WAT | 45 | — | 10.6 | 52.1 | 0.9% | +52% | 7% | 2% |
| IDXX | 44 | 39.4 | 9.9 | 27.9 | 2.8% | +13% | 32% | 49% |
| ILMN | 41 | 50.3 | 9.2 | 36.0 | 2.3% | +5% | 20% | 19% |
| MTD | 33 | 37.6 | 8.6 | 28.4 | 2.6% | +7% | 28% | 49% |
| LH | 27 | 27.2 | 2.3 | 14.8 | 4.3% | +6% | 10% | 9% |
| DGX | 27 | 24.1 | 2.6 | 13.6 | 5.2% | +9% | 15% | 11% |
| MEDP | 19 | 37.2 | 6.3 | 28.4 | 3.6% | +20% | 21% | — |
| RVTY | 18 | 76.0 | 6.8 | 25.8 | 3.2% | +4% | 12% | 3% |
| CRL | 16 | — | 4.7 | 48.7 | 2.2% | -0.7% | 2% | 1% |
| ICLR | 14 | — | 2.0 | 25.1 | 6.2% | +2% | 4% | 2% |
| Median of these 10 | 37.6 | 6.6 | 28.1 | 3.0% | +7% | 13% | 9% |
; EV/Sales 19.6 vs. 6.6.
Growth vs. price
each dot a company · hover or tap for valuesGH and WAT and CRL and ICLR have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Guardant Health, Inc. — questions
- What is Guardant Health, Inc.'s market cap?
- $22.7B.
- What is Guardant Health, Inc.'s price-to-sales ratio?
- 19.2.
Every figure on this page comes from Guardant Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.